Industry Articles

Articles

Cell & Gene Market Outlook

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…

Brandon Allison

Articles

CTMS Benchmarking & Market Dynamics

ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle clinical trial management systems (CTMS) by helping providers and sponsors alike better understand current trends surrounding this technology and anticipate future ones. This report is the result of primary…

Brandon Allison

Articles

Six Questions to Ask About Your Market Research

How do you ensure the research products and services you buy will make you confident in the decisions you make? Here are six reasons why Industry Standard Research ensures you are getting the value you should expect from quality market…

Brandon Allison

Articles

2019 Year In Review – An Overview Of Insights in Pharmaceutical Manufacturing, Clinical Research and Technology

How Pharma, CROs, and CDMOs can prepare for 2020 ISR conducted approximately two dozen individual pieces of market research for syndication in 2019. This webinar summarizes many of the important learnings from these projects, providing attendees with real, usable data…

Brandon Allison

Articles

Influence Of Size In CRO Selection

Vice President of Market Research at Industry Standard Research Rebecca McAvoy discusses whether the company size of a CRO has an impact on its therapeutic expertise, and by extension, an impact on outsourcing selection. CRO selection. Whether you’ve been in…

Brandon Allison

Articles

Decision-Makers Agree—Phase I Clinical Research is Becoming More Complex

Informing pharmaceutical drug developers, manufacturers, and service providers Raleigh, N.C. — October 16, 2018 — Industry Standard Research (ISR) announces the release of its newest report, “Phase I Study Trends and Market Outlook (2018-2022),” in which 143 Phase I decision-makers…

Brandon Allison

Press

Biotrial and SGS Life Sciences Receive High Marks for Accessibility

Phase I Outsourcers Value Attributes Like Patient Access Informing pharmaceutical drug developers, manufacturers, and service providers Raleigh, N.C. – September 27, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its CRO Quality Benchmarking…

Brandon Allison

Press

CRO Growth Continues, ISR Projects More Growth to Come

Informing the drug development and pharmaceutical manufacturing industry. Raleigh, N.C. – September 25, 2018 – Industry Standard Research (ISR) has announced the newest edition of its CRO market analysis report “2018 CRO Market Size Projections: 2017-2022.” For this report, ISR has…

Brandon Allison

Press

Large CROs Stand Out in Post-marketing Pharmacovigilance

Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – September 24, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its CRO Quality Benchmarking – Phase IV Service Providers series. ISR surveyed 230 decision-makers at sponsor…

Brandon Allison

Press

Big Pharma CMOs win for Biologic API and Alcami Scores Highest for Biologic Drug Product

ISR's latest Biologic API and Biologic Drug Product CDMO Benchmarking Reports have arrived Informing the pharmaceutical drug development, manufacturing and commercialization industry. Raleigh, NC – May 23, 2018 –Industry Standard Research’s (ISR’s) 3rd annual Biologic API Contract Manufacturer Quality Benchmarking…

Brandon Allison

Press

Accenture and Medpace Excel in Phase II/III Delivery Factors

The 10th Edition of ISR's Phase II/III CRO Benchmarking has arrived Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – May 17, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its…

Brandon Allison

Press

FLAMMA, Novasep and Alcami Win for Small Molecule Contract Manufacturing Performance

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 15, 2018 – Industry Standard Research's (ISR’s) annual Small Molecule API Contract Manufacturer Quality Benchmarking report reveals that FLAMMA and Novasep received the highest Overall Performance Scores based…

Brandon Allison

Resources